scholarly journals Effect of release-active anti-interferon-gamma antibodies on the course of the tumor process in in vivo experimental models

2018 ◽  
pp. 132-134
Author(s):  
Т.Г. Разина ◽  
И.А. Эртузун ◽  
Е.Н. Амосова ◽  
С.Г. Крылова ◽  
Е.П. Зуева ◽  
...  
Keyword(s):  
Tumor Growth ◽  
Interferon Gamma ◽  
Conformational Changes ◽  
Hematogenous Metastasis ◽  
Walker 256 Carcinosarcoma ◽  
Melanoma B16 ◽  
Enhanced Production ◽  
Walker 256 ◽  
Stimulation Of

Интерферон-гамма (ИФН) играет важную роль в иммунных механизмах сдерживания опухолевого процесса, однако в определенных условиях может оказывать проопухолевое действие. Релиз-активные антитела (РА АТ) к ИФН изменяют конформацию молекулы этого цитокина, облегчают его связывание с рецептором и усиливают продукцию эндогенного ИФН. Цель настоящего исследования состояла в изучении влияния РА АТ к ИФН на имеющийся опухолевый процесс на моделях меланомы и карциносаркомы. Методика. Было изучено влияние препарата на течение опухолевого процесса в моделях меланомы В-16 у мышей и карциносаркомы Уокера 256 у крыс. Результаты. У мышей с меланомой В-16, чувствительной к ИФН, тестируемый препарат не стимулировал рост и метастазирование опухоли. В модели карциносаркомы Уокера 256 у крыс РА АТ к ИФН также не влияли на размер опухоли, однако значительно ингибировали гематогенное метастазирование. Заключение. В настоящем исследовании не было выявлено стимулирования опухолевого процесса и метастазирования препаратом РА АТ к ИФН. Interferon-gamma (IFN) plays an important role in antitumor immunity; however, in some circumstances, it may also favor tumor immune evasion. Released-active (RA) anti-IFN antibodies (Abs) are able to induce conformational changes in the IFN molecule and to facilitate its receptor binding, which results in enhanced production of this cytokine. The aim of the present study was to evaluate the effect of RA anti-IFN Abs on the tumor growth in models of melanoma and carcinosarcoma. Methods. The ability of anti-IFN RA Abs to influence the tumor growth was evaluated in the models of melanoma B16 in mice and Walker 256 carcinosarcoma in rats. Results. The exposure of mice with IFN-sensitive melanoma B16 to the tested drug did not result in stimulation of tumor growth and metastasis. RA anti-IFN Abs also did not affect the tumor size in the rat model of Walker 256 carcinosarcoma but significantly inhibited the hematogenous metastasis. Conclusion. In the present study, no stimulation of the tumor process and metastasis by RA anti-IFN Abs were found.

THE INFLUENCE OF TUMOR GROWTH ON THE SYNTHESIS OF α2-AP (ACUTE PHASE) GLOBULIN OF RAT SERUM

1967 ◽  
Vol 45 (12) ◽  
pp. 1937-1941 ◽  
Author(s):  
Henry E. Weimer ◽  
Constance Humelbaugh ◽  
Dorothy M. Roberts
Keyword(s):  
Tumor Growth ◽  
Acute Phase ◽  
Tissue Injury ◽  
Sprague Dawley ◽  
Rat Serum ◽  
Serum Haptoglobin ◽  
Sprague Dawley Rats ◽  
Walker 256 ◽  
Implantation Procedure

The effects of growth of the Walker 256 carcinosarcoma on the α2-AP (acute phase) globulin, fibrinogen, seromucoid, and haptoglobin fractions of plasma were investigated in adult, male Sprague–Dawley rats in a longitudinal study. Early increases in α2-AP globulin and seromucoid levels were found to be related to the tissue injury associated with the implantation procedure. Significant elevations in the α2-AP globulin, fibrinogen, and seromucoid fractions coincided with the onset of progressive tumor growth. Serum haptoglobin concentrations exhibited a delayed rise. This was attributed to the in vivo formation of haptoglobin–hemoglobin complexes. It was suggested that the increases in all fractions reflected the release of humoral mediators from injured or necrotic cells wrhich stimulated increased synthesis of the fractions by the liver.

Dynamics of tumor growth in Brattleboro and WAG rats injected with Walker 256 carcinosarcoma cells in different doses

2008 ◽  
Vol 145 (1) ◽  
pp. 81-83 ◽  
Author(s):  
I. I. Khegay ◽  
N. A. Popova ◽  
L. S. Ganilova ◽  
E. P. Shnyder ◽  
L. N. Ivanova
Keyword(s):  
Tumor Growth ◽  
Walker 256 Carcinosarcoma ◽  
Walker 256 ◽  
Different Doses

BCR-mediated uptake of antigen linked to TLR9 ligand stimulates B-cell proliferation and antigen-specific plasma cell formation

Blood ◽  
2009 ◽  
Vol 113 (17) ◽  
pp. 3969-3977 ◽  
Author(s):  
Julia Eckl-Dorna ◽  
Facundo D. Batista
Keyword(s):  
Cell Proliferation ◽  
B Cells ◽  
B Cell ◽  
Plasma Cells ◽  
Cell Formation ◽  
Specific Class ◽  
B Cell Differentiation ◽  
Enhanced Production ◽  
Stimulation Of

Abstract The activation of Toll-like receptor 9 (TLR9) expressed within B cells is associated with enhanced humoral immunity. However the role of TLR9 in the stimulation of B-cell responses, and more specifically in shaping the outcome of B-cell differentiation, remains unclear. Here, we observed that immunization with the TLR9 agonist CpG linked to protein antigen gave rise to enhanced production of antigen-specific class-switched antibodies in vivo. Unlike dendritic cells, B cells are unable to acquire these conjugates by macropinocytosis and instead depend on uptake through a signaling-competent B-cell receptor (BCR), provided the overall BCR-antigen avidity exceeds a defined threshold. The resultant stimulation of intrinsic TLR9 leads to enhanced antigen-specific B-cell proliferation and differentiation to form extrafollicular plasma cells. Thus, the direct conjugation of antigen and CpG reveals a mechanism that may operate during the initiation of primary immune responses, and may prove useful as a strategy for the design of adjuvants suitable for vaccinations.

Autocrine tumor growth regulation and tumor-associated hypoglycemia in murine melanoma B16 in vivo

1987 ◽  
Vol 28 ◽  
pp. 124
Author(s):  
S. Levanat ◽  
S. Vuk-Pavlović ◽  
E.C. Opara ◽  
D. Vrbanac ◽  
K. Pavelić
Keyword(s):  
Tumor Growth ◽  
Growth Regulation ◽  
Murine Melanoma ◽  
Melanoma B16

scholarly journals Modulation of Endotoxin- and Enterotoxin-Induced Cytokine Release by In Vivo Treatment with β-(1,6)-Branched β-(1,3)-Glucan

1999 ◽  
Vol 67 (1) ◽  
pp. 244-252 ◽  
Author(s):  
Jindrich Soltys ◽  
Mark T. Quinn
Keyword(s):  
Proinflammatory Cytokines ◽  
Necrosis Factor Alpha ◽  
Enhanced Production ◽  
Tnf Α ◽  
Host Mortality ◽  
Toxic Shock Syndrome Toxin ◽  
Stimulation Of ◽  
In Cells

ABSTRACT Leukocytes activated by endotoxin or enterotoxins release proinflammatory cytokines, thereby contributing to the cascade of events leading to septic shock. In the present studies, we analyzed the effects of in vivo administration of a soluble immunomodulator, β-(1,6)-branched β-(1,3)-glucan (soluble β-glucan), on toxin-stimulated cytokine production in monocytes and lymphocytes isolated from treated mice. In vitro stimulation of lymphocytes isolated from soluble β-glucan-treated mice with lipopolysaccharide (LPS) resulted in enhanced production of interleukin-6 (IL-6) and suppressed production of tumor necrosis factor alpha (TNF-α), while stimulation of these cells with staphylococcal enterotoxin B (SEB) or toxic shock syndrome toxin 1 (TSST-1) resulted in enhanced production of gamma interferon (IFN-γ) and suppressed production of IL-2 and TNF-α compared to that in cells isolated from untreated mice. In vitro stimulation of monocytes isolated from soluble β-glucan-treated mice with LPS also resulted in suppressed TNF-α production, while stimulation of these cells with SEB or TSST-1 resulted in suppressed IL-6 and TNF-α production compared to that in cells isolated from untreated mice. Thus, the overall cytokine pattern of leukocytes from soluble β-glucan-treated mice reflects suppressed production of proinflammatory cytokines, especially TNF-α. Taken together, our results suggest that treatment with soluble β-glucan can modulate the induction cytokines during sepsis, resulting in an overall decrease in host mortality.

μ Opioid Receptor Stimulates a Growth Promoting and Pro-Angiogenic Tumor Microenvironment by Transactivating VEGF Receptor-2/Flk-1.

Blood ◽  
2005 ◽  
Vol 106 (11) ◽  
pp. 3687-3687
Author(s):  
Elliot J. Stephenson ◽  
Humberto J. Martinez-Suarez ◽  
Mariya Farooqui ◽  
Debabrata Mukhopadhyay ◽  
Deborah A. Hughes ◽  
...  
Keyword(s):  
Tumor Microenvironment ◽  
Tumor Growth ◽  
Opioid Receptor ◽  
Calcium Release ◽  
Small Gtpase ◽  
Endothelial Cell Proliferation ◽  
Vegf Receptor ◽  
Growth Promoting ◽  
Stimulation Of

Abstract Like VEGF, morphine stimulates MAPK/ERK and Akt, leading to the promotion of angiogenesis via NO dependent signaling (Cancer Res62: 4491, 2002). Morphine acts via pertussis toxin (PT)-dependent G-protein coupled receptors (GPCRS), while VEGF acts via receptor tyrosine kinases (RTKs). We showed that PT-dependent GPCRs transactivate VEGF receptor-2/Flk1 via small GTPase RhoA (JBC277: 4679, 2002; JBC278:20738, 2003). Therefore, we hypothesized that morphine via the mu opioid receptor (MOR) transactivates Flk1 and promotes a pro-angiogenic microenvironment. Morphine-induced proliferation of human umbilical vein endothelial cells (HUVEC) was completely abrogated by Y-27632 (100 μM), a highly selective and potent inhibitor of Rho-associated protein kinases, suggesting the activation of Rho signaling by morphine. Addition of 1 μM morphine potentiated VEGF-induced (10 ng/ml) proliferation of HUVEC by 25%. We observed a 30% increase in intracellular calcium release after VEGF stimulation of HUVEC pre-incubated with morphine as compared to HUVEC pre-incubated with PBS, detected by a change in the fluorescence ratio of the Fura-2 AM dye. These findings show that morphine, via MOR and Rho signaling, transactivates Flk1 leading to the stimulation of calcium signaling and endothelial cell proliferation. To functionally corroborate our hypothesis, we used MOR knockout (MOR-KO) mice and injected them with MOR-replete T241 fibrosarcoma cells. T241 fibrosarcoma tumor growth in vivo showed appearance of palpable and measurable tumors 2 days earlier in wild type (wt) as compared to MOR-KO mice. Tumor growth and angiogenesis were decreased by 20–35% in MOR-KO mice as compared to wt littermates during 3 weeks of tumor growth. None of the MOR-KO showed signs of lung metastasis versus 40% wt mice with metastasis. Morphine (1.42 for the first 2 wks and 2.14 mg/Kg/day later, respectively) stimulated 20–35% tumor growth in wt, but not in MOR-KO mice. Western immunoblotting showed a 10-fold increase in the expression of phospho-Flk1 in morphine treated wt tumors as compared to PBS-treated wt mice. Morphine did not stimulate phospho-Flk1 expression in MOR-KO mice. Western analysis of immunoprecipitates obtained with α-MOR antibody showed the expression of Flk1 and phospho-Flk1 in wt, but were not expressed in MOR-KO tumors. Thus, MOR stimulates the transactivation of Flk1 in wt mice but not in MOR-KO. These in vitro and in vivo data using MOR-KO mice and the MOR agonist, morphine, show that MOR stimulates endothelial proliferation, angiogenesis and promotes tumor growth and metastasis directly as well as by transactivating Flk1 phosphorylation. We speculate that MOR is a critical component of the ‘angiogenic switch’, which regulates the pro-angiogenic and growth promoting tumor microenvironment. Thus, MOR provides a novel target for developing anti-angiogenic therapies.

scholarly journals Chronic Stimulation of the Autophagy-inducing Ingredient of Areca Nut Promotes Tumor Growth In Vivo Through Up-regulation of Tumoral Autophagy

2019 ◽  
Vol 40 (1) ◽  
pp. 221-227
Author(s):  
CHANG-TA CHIU ◽  
SHYUN-YEU LIU ◽  
CHING-YU YEN ◽  
BANG-YEN LIU ◽  
ZI-YU SUN ◽  
...  
Keyword(s):  
Tumor Growth ◽  
Areca Nut ◽  
Chronic Stimulation ◽  
Stimulation Of

Synthese, in vivo- und in vitro-Untersuchungen zur tumorhemmenden Wirkung von cis-Dichloro-dipeptidester-platin(II)-Komplexen / Synthesis, in vivo and in vitro Studies on the Antineoplastic Effect of cis-Dichloro-dipeptide Ester Platinum(II) Complexes

1976 ◽  
Vol 31 (6) ◽  
pp. 832-845 ◽  
Author(s):  
Wolfgang Beck ◽  
Bernhard Purucker ◽  
Michael Girnth ◽  
Helmut Schönenberger ◽  
Horst Seidenberger ◽  
...  
Keyword(s):  
Protein Biosynthesis ◽  
Sarcoma 180 ◽  
Protecting Group ◽  
Yoshida Sarcoma ◽  
Walker 256 Carcinosarcoma ◽  
E Coli ◽  
Antineoplastic Effect ◽  
Walker 256

cis-Dichlorodipeptide esterplatinum complexesCl2Pt(MetGlyOEt),Cl2Pt(EthionylGlyOEt), Cl2Pt(GlyGlyOEt)2 and Cl2Pt(GlySerOEt)2 are prepared from the α-amino acid complexes by peptide synthesis using platinum as an amino protecting group. cis-Cl2Pt(GlyGlyOEt)2 and cis-Cl2Pt(GlySerOEt)2 have been prepared also directly from K2PtCl4 and the dipeptidesters. cis-Cl2Pt(GlyGlyOEt)2 (2 a) and cis-Cl2Pt(NH3)2 (5) lead to a prefered inhibition of the DNA-synthesis of sarcoma 180, Yoshida-sarcoma and Walker-256-carcinosarcoma in vitro; RNA- and protein biosynthesis are influenced to a much lower degree. 2a and 5 cause filamentous growth in Escherichia coli B. The DNA polymerase deficient strain of E. coli, p 3478 pol A-, is more inhibited by 2 a and 5 than the non deficient strain W 3110 pol A+. Tumor growth of di-2-chloro-ethylmethylamine (HN2) resistant sarcoma 180 and of Yoshida sarcoma is weakly inhibited, whereas Walker-256-carcinosarcoma is markedly inhibited; however 2a and 5 show similar inhibition of the same tumor.

scholarly journals MORPHOLOGICAL FEATURES OF DOXORUBICIN-RESISTANT WALKER 256 CARCINOSARCOMA AND RESPONSE OF MAST CELLS

2018 ◽  
Vol 40 (1) ◽  
pp. 42-47
Author(s):  
N V Boroday ◽  
V F Chekhun
Keyword(s):  
Drug Resistance ◽  
Mast Cells ◽  
Staining Intensity ◽  
Morphological Features ◽  
Histamine Content ◽  
Original Strain ◽  
Walker 256 Carcinosarcoma ◽  
Development Of Resistance ◽  
Walker 256

Background: The mechanisms of drug resistance of cancer have not been yet elucidated in details. Recently, the role of mast cells (MCs) in the development of drug resistance has been brought in the limelight. The aim of the study was to examine the morphological features of doxorubicin (DOX)-resistant Walker 256 carcinosarcoma and to assess the response of MCs and histamine content in these cells in relation to the development of resistance to DOX as well as in DOX-resistant tumors. Materials and Methods: The DOX resistance was induced by serial passages of Walker 256 carcinosarcoma in rats in the setting of DOX treatment in vivo. MCs in tumors were detected in the sections by staining with Toluidine Blue O. Histamine content in MCs stained with solution of Water Blue-Orcein was assessed by Astaldi semiquantitative method taking into account different staining intensity. Results: Formation of DOX resistance in the course of serial passages of Walker 256 carcinosarcoma was accompanied by the increase in the number of MCs in tumors and histamine content. Nevertheless, in tumors with phenotype of complete DOX resistance the number of histamine-containing MCs decreased to the same level as in tumors of the original strain that are DOX-sensitive. Conclusion: MCs are involved in formation of DOX resistance in Walker 256 carcinosarcoma.

Sign in / Sign up

Export Citation Format

Share Document